ScienceDex / Researcher record
Harshini Neelakantan
- Ridgeline Therapeutics, Inc. (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Rising Star
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $236,538 | 1 | #44,068 |
| 2025 | $1,339,717 | 1 | #11,866 |
| 2026 | $3,022,044 | 2 | #6,146 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20241 record
- FY20251 record
- FY2026 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15915596Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award records by amount
NIH award records listing Harshini Neelakantan as a PI. Multi-PI records show the full award amount for context.
- 1R44AG102216-01R44Contact PICardiovascular Safety and Scalable Manufacturing for Investigational New Drug Filing of a Novel Oral Drug to Accelerate Musculoskeletal Recovery in Older Adults$2.1Maward amount
- 5R44AG092210-02R44Contact PIPreclinical validation of a novel adjunct small molecule drug to prevent muscle loss and enhance weight loss in older adults$904.8Kaward amount
Award organization
Organizations that administered FY2026 awards listing Harshini Neelakantan as a PI.
FY2026 award administered by Ridgeline Therapeutics, Inc. (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardRidgeline Therapeutics, Inc.
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2026$2M Cumulative Funding
- 2026Entered Top 50% NationallyRanked #6146